Saturday 17 October 2026
Export AIM’s income statement to Excel — free account
AIM ImmunoTech Inc.
AIM ImmunoTech Inc.’s revenue for fiscal 2025 (year ended December 2025) was $88,000.00, down 48.2% from fiscal 2024. In the quarter to June 2026, revenue grew 4.00%, EPS grew 94.0% and free cash flow fell 167.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.17
0.00
0.00%
Follow AIM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
3 | 4 | 3 | 3 | 4 | 5 | 3 | 1 | 3 | 3 |
Altman Z-Score |
(113.91) | (77.07) | (33.28) | (9.45) | 22.10 | 2.63 | (23.37) | (34.53) | (31.92) | (21.80) |
P/S ratio |
20.23 | 63.93 | 112.00 | 105.78 | 312.90 | 339.14 | 5.02 | 20.93 | 22.22 | 160.04 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(266.06) | (181.31) | (76.77) | (8.29) | 55.87 | 4.71 | (50.61) | (80.67) | (74.22) | (50.43) |
Beneish M-Score |
— | — | (6.32) | (6.94) | — | — | — | — | — | — |
P/Operating CF |
(0.90) | (2.75) | (2.32) | (2.46) | (7.35) | (19.37) | (0.83) | (3.18) | (12.78) | (7.00) |
P/B ratio |
0.00 | 0.00 | 2.37 | 0.39 | 0.75 | 0.91 | 0.15 | 1.48 | 1.12 | 0.95 |
Price to Tangible BV |
0.00 | 0.00 | 3.13 | 0.42 | 0.78 | 0.94 | 0.17 | 1.80 | 1.24 | 1.01 |
EV/Sales |
(1.20) | 42.73 | 51.14 | (130.37) | (42.08) | 112.79 | (1.69) | 22.82 | 21.60 | 96.29 |
EV/EBITDA |
0.01 | 0.00 | 0.00 | 0.93 | 0.32 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.01 | (0.49) | (0.49) | 1.14 | 0.41 | (1.77) | 0.07 | (0.79) | (1.19) | (1.20) |
EV/FCF |
0.01 | (0.47) | (0.47) | 1.47 | 0.40 | (1.68) | 0.07 | (0.86) | (1.18) | (1.13) |
Quick Ratio |
0.49 | 0.42 | 1.65 | 26.35 | 74.16 | 36.41 | 8.52 | 0.55 | 0.79 | 2.41 |
Current Ratio |
0.53 | 0.44 | 1.68 | 26.69 | 74.61 | 36.58 | 9.27 | 0.72 | 1.29 | 2.85 |
Net Debt/EBITDA |
0.22 | 0.21 | 0.41 | 1.70 | 2.67 | 2.61 | 0.22 | (0.07) | 0.03 | 0.47 |
Debt/Assets |
16.03% | 0.00% | 0.00% | 1.63% | 0.19% | 3.26% | 30.01% | 18.18% | 12.92% | 0.00% |
Debt/Equity |
(0.09) | 0.00 | 0.00 | 0.02 | 0.00 | 0.03 | 0.46 | 0.49 | 0.21 | 0.00 |
Asset Turnover |
0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.00 |
Operating CF/Net income |
0.79 | 0.86 | 0.73 | 0.83 | 0.73 | 0.72 | 0.96 | 1.08 | 0.96 | 0.98 |
Capex/Depreciation |
(0.20) | (0.93) | (2.13) | 14.18 | (0.47) | (0.59) | (0.34) | 0.81 | (0.07) | (0.35) |
Interest Coverage |
(14.36) | (33.80) | — | (31.67) | (281.16) | (22.55) | (29.14) | (22.90) | (82.13) | (107.01) |
| 251.38% | (421.26%) | (122.42%) | (41.40%) | (32.77%) | (39.33%) | (105.44%) | (141.63%) | (68.25%) | (41.83%) | |
| (194.00%) | (123.76%) | (96.75%) | (39.61%) | (31.28%) | (33.75%) | (54.36%) | (70.06%) | (49.93%) | (36.00%) | |
ROIC |
0.00% | 0.00% | 0.00% | (252.22%) | (134.97%) | (38.81%) | (71.40%) | (122.49%) | (84.63%) | (89.59%) |
Return on Tangible Assets |
488.38% | 329.84% | (480.22%) | (55.31%) | (35.69%) | (31.52%) | (57.22%) | (156.26%) | (88.01%) | (53.51%) |
Average Days of Receivables |
29.03 | 0.00 | 2,139.41 | 4,338.58 | 4,436.78 | 2,516.93 | 2,137.86 | 1,088.04 | 20.05 | 0.00 |
Research and Development Expense of Revenue |
4,459.09% | 3,645.29% | 5,415.35% | 4,957.45% | 5,682.96% | 3,509.20% | 3,322.14% | 1,301.91% | 937.76% | 5,551.09% |
Selling, General and Administrative Expense of Revenue |
8,750.00% | 8,067.06% | 10,463.86% | 9,272.34% | 6,423.70% | 5,309.20% | 5,027.86% | 1,689.65% | 1,503.89% | 8,348.91% |
Intangible Assets out of Total Assets |
0.29 | 0.30 | 0.12 | 0.05 | 0.03 | 0.02 | 0.06 | 0.07 | 0.06 | 0.05 |
Share Based Compensation of Revenue |
68.18% | 403.53% | 120.30% | 676.60% | 1,161.48% | 635.58% | 609.29% | 253.13% | 130.66% | 445.65% |
Graham Net Nets |
(6.89) | (0.53) | 0.24 | 2.30 | 1.17 | 0.67 | 1.64 | (0.63) | (0.21) | 0.24 |
Graham Number |
38.13 | 40.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(971.82%) | (159.79%) | (128.87%) | (128.87%) | (44.83%) | (28.80%) | (525.48%) | (126.16%) | (85.53%) | (52.82%) |
Free Cash Flow Yield |
(636.97%) | (142.00%) | (98.05%) | (83.77%) | (34.00%) | (19.83%) | (494.69%) | (126.49%) | (82.50%) | (53.30%) |
Revenue per Share |
0.05 | 0.30 | 0.42 | 0.29 | 0.29 | 0.51 | 3.85 | 36.70 | 67.23 | 18.40 |
Operating CF per Share |
(6.77) | (26.58) | (43.77) | (33.52) | (29.50) | (32.56) | (249.09) | (1,064.00) | (1,221.69) | (1,476.00) |
Capex per Share |
(0.23) | (0.99) | (1.11) | 7.55 | (0.82) | (1.87) | (10.03) | 92.30 | (10.62) | (90.80) |
Free Cash Flow per Share |
(7.00) | (27.57) | (44.88) | (25.97) | (30.32) | (34.43) | (259.12) | (971.70) | (1,232.31) | (1,566.80) |
Cash per Share |
1.88 | 7.10 | 26.90 | 71.16 | 101.96 | 122.49 | 241.15 | 182.50 | 324.15 | 1,173.60 |
Shareholders Equity per Share |
(6.04) | (2.36) | 21.06 | 80.06 | 120.15 | 192.51 | 369.29 | 517.40 | 1,338.92 | 3,099.60 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(6.04) | (2.36) | 21.06 | 80.06 | 120.15 | 192.51 | 369.29 | 517.40 | 1,338.92 | 3,099.60 |
Free Cash Flow |
(11.33) | (15.44) | (21.80) | (12.48) | (14.35) | (10.96) | (9.43) | (9.72) | (8.01) | (7.83) |
Working Capital |
(2.93) | (5.36) | 5.90 | 34.96 | 49.54 | 39.21 | 9.32 | (1.49) | 0.80 | 4.51 |
Capital Expenditures |
(0.38) | (0.56) | (0.54) | 3.63 | (0.39) | (0.59) | (0.36) | 0.92 | (0.07) | (0.45) |
Net Current Asset Value |
(12.27) | (5.75) | 5.41 | 34.30 | 49.39 | 37.02 | 3.13 | (4.87) | (2.00) | 3.57 |
EV/EBIT |
0.01 | 0.00 | 0.00 | 0.92 | 0.30 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
4.30 | 3.27 | 2.66 | (25.74) | 2.87 | 3.65 | 2.61 | (2.51) | 0.16 | 4.93 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
26.76 | 5.51 | 1.98 | 1.31 | 0.20 | 0.16 | 0.15 | 0.15 | 0.12 | 0.14 |
Cash ROIC |
195.13% | (581.69%) | (93.57%) | (17.02%) | (13.64%) | (10.71%) | (33.16%) | (102.11%) | (63.35%) | (36.67%) |
Accounts Receivable Turnover |
0.15 | 0.00 | 0.14 | 0.09 | 0.10 | 0.17 | 0.15 | 0.66 | 0.78 | 0.00 |
Accounts Payable Turnover |
0.03 | 0.00 | 0.01 | (1.47) | 2.93 | 1.89 | 1.55 | 1.24 | 1.45 | 1.06 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
4,648.05 | 75,154.68 | 55,992.74 | (324.54) | 85.02 | 173.44 | 192.92 | 280.77 | 228.63 | 292.20 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.60 | — | 1.43 | 1.66 | 1.38 | 0.97 | 0.96 | 0.56 | 0.56 | — |
Average Payables |
4.01 | 6.41 | 3.41 | 0.29 | 0.29 | 0.43 | 0.58 | 0.71 | 0.81 | 1.05 |
Average Assets |
7.20 | 13.99 | 29.93 | 49.09 | 61.14 | 42.67 | 17.30 | 14.03 | 16.54 | 20.84 |
Average Common Equity |
(5.55) | 4.11 | 23.66 | 46.97 | 58.36 | 36.61 | 8.92 | 6.94 | 12.10 | 17.93 |
Columns are period end dates